Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.

Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin NE.

Eur J Radiol. 2009 Dec;72(3):517-28. doi: 10.1016/j.ejrad.2008.08.008. Epub 2008 Oct 1. Review.

PMID:
18829195
2.

Transarterial liver-directed therapies of neuroendocrine hepatic metastases.

Nazario J, Gupta S.

Semin Oncol. 2010 Apr;37(2):118-26. doi: 10.1053/j.seminoncol.2010.03.004.

PMID:
20494704
3.

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.

Fiore F, Del Prete M, Franco R, Marotta V, Ramundo V, Marciello F, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A.

Endocrine. 2014 Sep;47(1):177-82. doi: 10.1007/s12020-013-0130-9. Epub 2014 Jan 3.

PMID:
24385266
4.

Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.

Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO.

J Vasc Interv Radiol. 2007 Jul;18(7):847-55.

PMID:
17609443
5.

[Chemoperfusion and embolization in the treatment of liver metastases].

Vogl TJ, Mack MG, Eichler K, Zangos S, Naguib NN, Gruber-Rouh T.

Rofo. 2011 Jan;183(1):12-23. doi: 10.1055/s-0029-1245880. Epub 2010 Nov 26. Review. German.

PMID:
21113865
6.

Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma.

Vogl TJ, Jost A, Nour-Eldin NA, Mack MG, Zangos S, Naguib NN.

Br J Cancer. 2012 Mar 27;106(7):1274-9. doi: 10.1038/bjc.2012.69. Epub 2012 Mar 1.

7.

Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.

Vogl TJ, Naguib NN, Nour-Eldin NE, Rao P, Emami AH, Zangos S, Nabil M, Abdelkader A.

Eur J Radiol. 2009 Dec;72(3):505-16. doi: 10.1016/j.ejrad.2008.08.007. Epub 2008 Oct 2. Review.

PMID:
18835117
8.

Interventional therapies of unresectable liver metastases.

Qian J.

J Cancer Res Clin Oncol. 2011 Dec;137(12):1763-72. doi: 10.1007/s00432-011-1026-9. Epub 2011 Sep 11. Review.

PMID:
21909952
9.

Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.

Kvols LK, Turaga KK, Strosberg J, Choi J.

J Natl Compr Canc Netw. 2009 Jul;7(7):765-72.

PMID:
19635229
10.

[Transarterial chemoembolization of liver metastases: Indication, technique, results].

Vogl TJ, Zangos S, Balzer JO, Thalhammer A, Mack MG.

Rofo. 2002 Jun;174(6):675-83. German.

PMID:
12063595
11.

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.

Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA.

Cancer J. 2003 Jul-Aug;9(4):261-7.

PMID:
12967136
12.

Neuroendocrine hepatic metastases: does aggressive management improve survival?

Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA.

Ann Surg. 2005 May;241(5):776-83; discussion 783-5.

13.

[Arterial embolization of hepatic metastases from neuroendocrine tumors].

Libicher M, Bovenschulte H.

Radiologe. 2009 Mar;49(3):233-41. doi: 10.1007/s00117-008-1787-6. Review. German.

PMID:
19183927
14.

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.

Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC.

Cancer. 2005 Oct 15;104(8):1590-602.

15.

Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.

Arrese D, McNally ME, Chokshi R, Feria-Arias E, Schmidt C, Klemanski D, Gregory G, Khabiri H, Shah M, Bloomston M.

Ann Surg Oncol. 2013 Apr;20(4):1114-20. doi: 10.1245/s10434-012-2786-4. Epub 2013 Mar 2.

PMID:
23456380
16.

Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases.

Kamat PP, Gupta S, Ensor JE, Murthy R, Ahrar K, Madoff DC, Wallace MJ, Hicks ME.

Cardiovasc Intervent Radiol. 2008 Mar-Apr;31(2):299-307. Epub 2007 Oct 6.

PMID:
17922160
17.

Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.

Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.

Eur J Radiol. 2012 Mar;81(3):e189-93. doi: 10.1016/j.ejrad.2011.01.122. Epub 2011 Feb 25.

PMID:
21353417
18.

[Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors].

Fujisaki T, Ikari T, Kamei A, Takano K, Kuraoka K, Yoshimoto K, Hirasawa T, Asahara S.

Nihon Shokakibyo Gakkai Zasshi. 2008 Feb;105(2):206-13. Japanese.

PMID:
18250591
19.

Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.

Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.

Am Surg. 2002 Sep;68(9):827-31.

PMID:
12356160
20.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278

Supplemental Content

Support Center